Introduction: Ruthenium-106 brachytherapy is a primary treatment for Uveal Melanoma (UM), the most common intraocular malignancy in adults. This study evaluated the safety of Ru-106 applicators at 3 T
The study involves the planned use of a new microwave-based device during colonoscopy procedures in a small group of patients to assess the preliminary safety of its use and lack of normal clinical pr
Introduction: Ruthenium-106 brachytherapy is a primary treatment for Uveal Melanoma (UM), the most common intraocular malignancy in adults. This study evaluated the safety of Ru-106 applicators at 3 T
